Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joachim C Mertens

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Inflammatory Intestinal Diseases|June 21, 2018
Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?Atsushi Tanaka, Joachim C Mertens
Oncotarget|January 24, 2013
Targeting tumor stroma: exploiting apoptotic primingJoachim C Mertens, Gregory J Gores
Praxis|November 20, 2008
[Diagnosis and therapy of rheumatoid arthritis]Joachim C Mertens, Vladimir Kaplan, Adrian Ciurea
International Journal of Molecular Sciences|January 22, 2021
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?Karen Claesen, Joachim C Mertens, Dorien Leenaerts, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 29, 2017
Targeting cholangiocarcinomaJoachim C Mertens, Sumera I Ilyas, Gregory J Gores
Digestion|August 31, 2017
Nonampullary Duodenal Adenomas Rarely Recur after Complete Endoscopic Resection: A Swiss Experience Including a Literature ReviewPiero V Valli, Joachim C Mertens, Amnon Sonnenberg, et al.
Pharmaceutics|October 23, 2021
Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced AtherosclerosisKaren Claesen, Lynn Roth, Joachim C Mertens, et al.
Journal of Thrombosis and Haemostasis : JTH|March 20, 2019
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysisJoachim C Mertens, Karen Claesen, Dorien Leenaerts, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Contrast-enhanced ultrasound of histologically proven liver hemangiomasChristoph F Dietrich, Joachim C Mertens, Barbara Braden, et al.
Biological Chemistry|September 28, 2010
Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-miceIna V Martin, Johannes Schmitt, Alexander Minkenberg, et al.
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Inflammatory Intestinal Diseases|June 21, 2018
Ulcerative Colitis with and without Primary Sclerosing Cholangitis: Two Different Diseases?Atsushi Tanaka, Joachim C Mertens
Oncotarget|January 24, 2013
Targeting tumor stroma: exploiting apoptotic primingJoachim C Mertens, Gregory J Gores
Praxis|November 20, 2008
[Diagnosis and therapy of rheumatoid arthritis]Joachim C Mertens, Vladimir Kaplan, Adrian Ciurea
International Journal of Molecular Sciences|January 22, 2021
Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Disease: What Do We Know Three Decades after Its Discovery?Karen Claesen, Joachim C Mertens, Dorien Leenaerts, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|August 29, 2017
Targeting cholangiocarcinomaJoachim C Mertens, Sumera I Ilyas, Gregory J Gores
Digestion|August 31, 2017
Nonampullary Duodenal Adenomas Rarely Recur after Complete Endoscopic Resection: A Swiss Experience Including a Literature ReviewPiero V Valli, Joachim C Mertens, Amnon Sonnenberg, et al.
Pharmaceutics|October 23, 2021
Pleiotropic Effects of Atorvastatin Result in a Downregulation of the Carboxypeptidase U System (CPU, TAFIa, CPB2) in a Mouse Model of Advanced AtherosclerosisKaren Claesen, Lynn Roth, Joachim C Mertens, et al.
Journal of Thrombosis and Haemostasis : JTH|March 20, 2019
Inhibition of the procarboxypeptidase U (proCPU, TAFI, proCPB2) system due to hemolysisJoachim C Mertens, Karen Claesen, Dorien Leenaerts, et al.
Hepatology (Baltimore, Md.)|April 28, 2007
Contrast-enhanced ultrasound of histologically proven liver hemangiomasChristoph F Dietrich, Joachim C Mertens, Barbara Braden, et al.
Biological Chemistry|September 28, 2010
Bile acid retention and activation of endogenous hepatic farnesoid-X-receptor in the pathogenesis of fatty liver disease in ob/ob-miceIna V Martin, Johannes Schmitt, Alexander Minkenberg, et al.
Pageof 5